Boston Scientific initiates study of neurostimulation device

06/19/2013 | RTT News

A patient at Cedars-Sinai in Los Angeles became the first to be implanted with Boston Scientific's Vercise DBS System. The implantation is part of a clinical trial to test whether the neurostimulation device can be used safely and effectively to improve overall quality of life and motor function in patients with Parkinson's disease.

View Full Article in:

RTT News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX